For over six decades, Bio-Rad has provided the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. As a leading global provider of in-vitro diagnostics supplies, our diagnostic products and systems leverage a broad range of technologies and deliver high-value clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. These products are used to support the diagnosis, monitoring, and treatment of diseases and other medical conditions. Bio-Rad is the world leader in clinical quality control products, services, and information systems, products that ensure the accuracy and validity of clinical test results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. In 2018, we are in our 66th year of operation. With a global network of operations and over 8,000 employees, we are helping people live longer, healthier lives.
The EDX SARS-CoV-2 Positive Run Control is manufactured with synthetic RNA transcript containing 5 gene targets (E, N, S, ORF1a, and RdRP genes of SARS CoV-2, 200,000 copies/mL each). The product is formulated in a synthetic matrix and contains human genomic DNA(75,000 copies/mL). 5 vials, 0.3mL Fill Volume, -20℃ or below Storage